Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Penile Neoplasms | 4 | 2019 | 161 | 0.600 |
Why?
|
| Noise | 1 | 2016 | 29 | 0.580 |
Why?
|
| Verbal Behavior | 1 | 2016 | 62 | 0.570 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2016 | 55 | 0.560 |
Why?
|
| Operating Rooms | 1 | 2016 | 122 | 0.530 |
Why?
|
| Communication | 1 | 2016 | 876 | 0.360 |
Why?
|
| Lymph Node Excision | 3 | 2019 | 1959 | 0.290 |
Why?
|
| Lymphatic Metastasis | 3 | 2019 | 4844 | 0.200 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2022 | 2341 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2019 | 5437 | 0.170 |
Why?
|
| Urologic Surgical Procedures | 1 | 2018 | 93 | 0.160 |
Why?
|
| Lithotripsy, Laser | 1 | 2017 | 8 | 0.150 |
Why?
|
| Calculi | 1 | 2017 | 14 | 0.150 |
Why?
|
| Kidney Calculi | 1 | 2017 | 40 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2021 | 548 | 0.150 |
Why?
|
| Urologic Neoplasms | 1 | 2019 | 188 | 0.150 |
Why?
|
| Music | 1 | 2016 | 36 | 0.140 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2022 | 962 | 0.130 |
Why?
|
| Inguinal Canal | 3 | 2019 | 60 | 0.130 |
Why?
|
| Endoscopy | 1 | 2018 | 479 | 0.130 |
Why?
|
| Medical Errors | 1 | 2016 | 219 | 0.120 |
Why?
|
| Nephrectomy | 1 | 2017 | 779 | 0.100 |
Why?
|
| Skin Physiological Phenomena | 1 | 2011 | 43 | 0.100 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 1271 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2016 | 1529 | 0.100 |
Why?
|
| Dermatology | 1 | 2011 | 70 | 0.100 |
Why?
|
| Patient Safety | 1 | 2016 | 649 | 0.100 |
Why?
|
| Physical Examination | 1 | 2011 | 299 | 0.090 |
Why?
|
| Cholecystokinin | 1 | 2009 | 45 | 0.090 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 42 | 0.090 |
Why?
|
| Postoperative Complications | 3 | 2021 | 5542 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2019 | 2967 | 0.080 |
Why?
|
| Cystectomy | 2 | 2022 | 623 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2017 | 1225 | 0.080 |
Why?
|
| Pancreas | 1 | 2009 | 718 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2022 | 32848 | 0.060 |
Why?
|
| Equipment Design | 2 | 2018 | 1204 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2009 | 1271 | 0.060 |
Why?
|
| Neoplasm Staging | 4 | 2019 | 13658 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 5767 | 0.060 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2019 | 1415 | 0.050 |
Why?
|
| Muscles | 1 | 2022 | 416 | 0.050 |
Why?
|
| Humans | 12 | 2022 | 261506 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 259 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 5112 | 0.040 |
Why?
|
| Male | 8 | 2021 | 123000 | 0.040 |
Why?
|
| Niobium | 1 | 2017 | 1 | 0.040 |
Why?
|
| Foot | 1 | 2018 | 104 | 0.040 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 16 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2017 | 50 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 4975 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2017 | 220 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 661 | 0.040 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 195 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2022 | 1353 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2017 | 169 | 0.040 |
Why?
|
| Operative Time | 1 | 2017 | 217 | 0.030 |
Why?
|
| Sentinel Lymph Node | 1 | 2018 | 216 | 0.030 |
Why?
|
| Quality of Life | 2 | 2020 | 4532 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 500 | 0.030 |
Why?
|
| Cisplatin | 1 | 2022 | 2432 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 2292 | 0.030 |
Why?
|
| Cicatrix | 1 | 2017 | 208 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 309 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2022 | 37905 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 3981 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 12873 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 1052 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1541 | 0.030 |
Why?
|
| Sebum | 1 | 2011 | 2 | 0.030 |
Why?
|
| Skin Pigmentation | 1 | 2011 | 47 | 0.030 |
Why?
|
| Skin Aging | 1 | 2011 | 56 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 21713 | 0.020 |
Why?
|
| Esthetics | 1 | 2011 | 189 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 585 | 0.020 |
Why?
|
| Trypsinogen | 1 | 2009 | 8 | 0.020 |
Why?
|
| Maleimides | 1 | 2009 | 22 | 0.020 |
Why?
|
| Acetophenones | 1 | 2009 | 19 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2018 | 2054 | 0.020 |
Why?
|
| Benzopyrans | 1 | 2009 | 41 | 0.020 |
Why?
|
| Abdomen | 1 | 2011 | 332 | 0.020 |
Why?
|
| Amylases | 1 | 2009 | 66 | 0.020 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 1946 | 0.020 |
Why?
|
| Face | 1 | 2011 | 273 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2009 | 206 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 886 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8865 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 86204 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 2139 | 0.020 |
Why?
|
| Skin | 1 | 2011 | 1259 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12221 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2019 | 3341 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 2063 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 14889 | 0.010 |
Why?
|
| Indoles | 1 | 2009 | 1009 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 7222 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 12926 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2009 | 1549 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 17523 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 5377 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 1879 | 0.010 |
Why?
|
| Female | 3 | 2021 | 141928 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 4938 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 5637 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 6086 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 15862 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 5710 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 10331 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 59536 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 6942 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 70117 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 21445 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 31252 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 34495 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 77950 | 0.000 |
Why?
|